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Abstract The antimicrobial drug candidate 1,3-
dibenzyl-4,5-diphenyl-imidazol-2-ylidene silver(I) ace-
tate (SBC3) was evaluated for its ability to function
in vivo using larvae of Galleria mellonella. A SBC3
concentration of 25 lg/ml inhibited the growth of
Staphylococcus aureus by 71.2 % and Candida albi-
cans by 86.2 % in vitro. Larvae inoculated with 20 ll
of SBC3 solution showed no ill effects up to a
concentration of 250 lg/ml but administration of
500 lg/ml resulted in a 40 % reduction in larval
survival and administration of a dose of 1,000 lg/ml
resulted in total larval death at 24 h. Larvae inoculated
with S. aureus or C. albicans and subsequently
administered SBC3 showed increased survival. Admin-
istration of SBC3 to larvae did not boost the insect
immune response as indicated by lack of an increase in
the density of circulating haemocytes (immune cells).
The abundance of a number of proteins involved in the
insect immune response was reduced in larvae that
received 20 ll SBC3 solution of 100 lg/ml. This is the
first demonstration of the in vivo activity of SBC3
against S. aureus and C. albicans and demonstrates that
SBC3 does not stimulate a non-specific immune
response in larvae.
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Introduction
Extensive use and misuse of the available antibiotic
arsenal and the shortage of new drugs reaching the
market have made antimicrobial resistance a major
threat to healthcare worldwide (Maple et al. 1989).
The continuous development of novel resistance-
disrupting antimicrobial drugs should therefore be a
prime activity of industry and academia (Rex 2014).
There is significant unexplored space for antimicrobial
silver-based drugs (Mijnendonckx et al. 2013; Oehn-
inger et al. 2013) and it has been suggested that
carbene-silver acetates derived from methylated caf-
feine may have the stability and antibiotic activity to
become drug candidates (Kascatan-Nebioglu et al.
2006; Hindi et al. 2008). This idea led to the
development of more lipophilic benzyl-substituted
imidazole- and benzimidazole-derived carbene-silver
complexes showing activity against Gram-positive
and Gram-negative bacteria (Hackenberg and Tacke
2014; Patil and Tacke 2011). So far, the most
promising derivative is 1,3-dibenzyl-4,5-diphenyl-
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imidazol-2-ylidene silver(I) acetate (SBC3) (Patil
et al. 2011) (Fig. 1). SBC3 shows MIC values ranging
from 20 to 3.13 lg/ml against Methicillin-sensitive
and -resistant Staphylococcus aureus as well as
Salmonella, Escherichia coli and Pseudomonas aeru-
ginosa (Sharkey et al. 2012).
Evaluating the in vivo efficacy and stability of novel
antimicrobial compounds is possible using insects. The
insect immune system shows many similarities to the
innate immune system of mammals (Kavanagh and
Reeves 2004; Browne et al. 2013) and, as a conse-
quence, insects have been used asmodels tomeasure the
virulence ofmicrobial pathogens (Fuchs andMylonakis
2006) and to evaluate the potency of antimicrobial drugs
(Hamamoto et al. 2004; Lionakis et al. 2005; Lionakis
and Kontoyiannis 2005; Rowan et al. 2009) and give
results consistent with those that can be obtained using
mammals (Jander et al. 2000; Brennan et al. 2002). A
number of insect species can beemployed for evaluating
the in vivo activity of novel antimicrobial drugs
(Kavanagh and Fallon 2010) and larvae of the Greater
Wax Moth,Galleria mellonella are now widely used in
this capacity (Kelly and Kavanagh 2011; Rowan et al.
2009; Desbois and Coote 2012).
This paper describes the antimicrobial effects of
SBC3 against the bacterium S. aureus and the yeast
Candida albicans in vitro and demonstrates the in vivo
activity and toxicity of SBC3 against these two
pathogens in G. mellonella larvae.
Materials and methods
Synthesis of SBC3
SBC3 (1,3-dibenzyl-4,5-diphenyl-imidazol-2-ylidene
silver(I) acetate) was synthesised as published (Patil
et al. 2011) and dissolved in a minimal amount of
DMSO (dimethylsulfoxide) before being diluted with
water-based media as described.
Inoculation of G. mellonella larvae
Sixth instar larvae of G. mellonella (Lepidoptera:
Pyralidae, the Greater Wax Moth) (Mealworm Com-
pany, Sheffield, England) were stored in the dark at
15 C (Cotter et al. 2000; Hornsey and Wareham
2011). Larvae of the same age and weighing 0.3 g
were inoculated with 20 ll of PBS containing 1 9 106
C. albicans cells or 4 9 107 S. aureus cells through the
last pro-leg using a Myjector U100 insulin syringe
(Terumo Europe, Leuven, Belgium).
Microbial cell culture
Staphylococcus aureus was cultured to the stationary
phase (OD600nm = 2) overnight in nutrient broth at
37 C and 200 rpm. C. albicans was cultured to the
stationary phase (approx. 1 9 108/ml) overnight in
YEPD broth (2 % (w/v) glucose, 2 % (w/v) bacteri-
ological peptone, 1 % (w/v) yeast extract) at 30 C and
200 rpm.
Effect of SBC3 on growth of S. aureus and C.
albicans
To each well of a 96–well plate (Sarsdedt), 100 ll of
fresh nutrient broth medium (for S. aureus growth) or
minimal medium (2 % (w/v) glucose, 0.17 % (w/v)
yeast nitrogen base and 0.5 % (w/v) ammonium
sulphate) (for C. albicans growth) were added. A
serial dilution of SBC3 was perfomed on the plate to
give a concentration range of 0.39–100 lg/ml. Cell
suspensions (100 ll) of S. aureus (4 9 107 cells/ml)
or C. albicans (1 9 106 cells/ml) were added to each
well and the plates were incubated at 37 or 30 C,
respectively, for 24 h. The OD570nm of the cultures
was determined using a microplate reader (Bio-Tek,
Synergy HT) and all growth was expressed as a
percentage of that in the control. All susceptibility
assays were performed on three separate occasions.
In vivo toxicity assay
Larvae were injected with 20 ll of SBC3 solution (10,
100, 250, 500 or 1,000 lg/ml) or 5 % (v/v) DMSO
Fig. 1 Molecular structure of SBC3
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through the last left pro-leg as described. Larvae were
incubated at 30 C for 24 h prior to quantifying
survival.
Effect of SBC3 on survival of larvae infected
with S. aureus or C. albicans
Larvae were injected with 20 ll of SBC3 solution (10,
100 or 250 lg/ml) 4 h post-inoculation with S. aureus
or C. albicans. The control consisted of larvae
inoculated with the C. albicans or S. aureus. Larvae
were incubated at 30 C and survival was assessed at
24, 48 and 72 h.
Determination of larval haemocyte density
The density of circulating haemocytes in larvae was
assessed as described previously (Rowan et al. 2009).
Experiments were performed on three independent
occasions and the mean ± SE were determined.
2 D SDS-PAGE analysis of protein expression
in larvae administered SBC3
Haemolymph (100 ll) was collected from larvae
inoculated with 20 ll SBC3 (100 lg/ml) or 5 % (v/
v) DMSO following incubation at 30 C for 24 h.
Protein concentration was determined by Bradford
assay and protein was diluted to 200 lg per sample.
Isoelectric focusing of protein samples on a pH 4-7
strip and 2D electrophoresis was performed as
described previously (Bergin et al. 2006). Each 2D
gel was scanned on a Hewlett Packard scanjet 5100c
scanner and the images were analyzed using Progen-
esis SameSpot Software. The Progenesis software
enabled the analysis of protein expression changes
between gel replicates with significance determined
using ANOVA. A table of protein spots was built and
every protein was linked to the matching proteins
between the gels creating a list of proteins that can be
cross referenced as a final check to ensure correct
alignment.
LC/MS analysis of peptides
In-gel digestion was performed on 2-Dimensional gel
spots of interest from a reference gel. The gel pieces
were excised, trypsin digested (Shevchenko et al.
2006) and fragmented protein samples were eluted
through the LC/MS (Aglient 6340 Ion Trap) which
determines the relative charge to mass ratio from
detected ionized particles. The data were analysed
using the mascot search engine to identify the protein
(\http://www.matrixscience.com) or via (*) Spectrum
Mill MS Proteomics. MASCOT scores above 67 are
deemed to have a significant match (p\ 0.05). The
mass error tolerance was 1 Da allowing for a maxi-
mum of no more than two missed cleavages. Verifi-
cation of protein sequences was confirmed by blasting
the protein sequence on the Uniprot (www.uniprot.
org) and NCBI (www.ncbi.nlm.nih.gov) websites.
Progenesis was used to determine the protein fold
changes between 2-Dimensional gels.
Statistical analysis
All experiments were performed on three independent
occasions and results are expressed as the mean ± SE.
Changes in larval survival were analysed with the log
rank (Mantel-Cox) method using GraphPad Prism
version 5.00. Analysis of changes in haemocyte
density, in vitro toxicity and protein expression were
performed by One-way ANOVA using GraphPad
Prism version 5.00 for Windows 8, GraphPad Soft-
ware, San Diego, California USA, (www.graphpad.
com).
Results
Determination of in vitro efficacy of SBC3 against
S. aureus and C. albicans
The effect of SBC3 on the growth of S. aureus and C.
albicans was measured as described. In the case of S.
aureus a concentration of 25 lg/ml resulted in
71.2 ± 1.28 % (p\ 0.001) inhibition of growth
(Fig. 2) while the same concentration resulted in
86.2 ± 1.42 % (p\ 0.001) inhibition in the growth of
C. albicans (Fig. 2). Both microbes appear susceptible
to SBC3 but there appears to be greater inhibition of
the growth of C. albicans than S. aureus at the higher
concentrations ([25 lg/ml).
Determination of effect of SBC3 on larval viability
The effect of SBC3 on the viability of G. mellonella
larvae was assessed as described. The results (Fig. 3)
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indicate no toxic effect up to a concentration of
250 lg/ml however larvae inoculated with a dose of
500 lg/ml showed a 40.0 ± 11.54 % (p\ 0.01)
reduction in viability after 24 h. Larvae inoculated
with SBC3 (10, 100, 250 lg/ml) did not show signs of
cuticular darkening (melanisation) which would be an
indicator of acute toxicity.
Effect of SBC3 on survival of larvae infected
with S. aureus or C. albicans
In order to ascertain the in vivo activity of SBC3,
larvae were infected with each pathogen as described
and subsequently administered 20 ll of SBC3 (10,
100 or 250 lg/ml) 4 h post infection. Those larvae
infected with S. aureus showed 15 ± 5.0 % survival
at 72 h however the larvae administered a dose of 10,
100 or 250 lg/ml SBC3 showed 46.7 ± 12.01 %
(p\ 0.05), 36.7 ± 3.33 % and 40.0 ± 5.77 % sur-
vival, respectively, at the same time point (Fig. 4a).
Larvae inoculated with C. albicans alone showed
100 % mortality at 48 h. However those larvae
inoculated with a dose of 10, 100 or 250 lg/ml
SBC3 subsequent to infection showed 30 ± 5.77 %
(p\ 0.01), 16.7 ± 6.66 % (p\ 0.05) and
13.3 ± 3.33 % (p\ 0.05) survival at the same time
point, respectively (Fig. 4b).
Assessment of the effect of SBC3 on the immune
response G. mellonella larvae
The cellular immune response of insects is mediated
by immune cells (haemocytes) which phagocytose and
kill invading pathogens (Lavine and Strand 2002) and
by the production of antimicrobial peptides (Boman
and Hultmark 1987). Previous work has demonstrated
that introduction of selected agents (e.g. silver nitrate,
caspofungin, b-glucan) into the haemocoel of G.
mellonella larvae can prime the immune response and
lead to an increase in the density of circulating
haemocytes and in the expression of antimicrobial and
immune related peptides (Rowan et al. 2009; Kelly
and Kavanagh 2011; Mowlds et al. 2010). In order to
exclude the possibility that the observed in vivo
antimicrobial activity of SBC3 was due to the
increased density of immune cells in the larvae, the
density of circulating haemocytes in larvae was
assessed. The results indicate that there was no
significant change in the haemocyte density in those
larvae that received doses of 10 and 100 lg/ml SBC3
(Fig. 5). Those larvae that received 20 ll doses of 500
or 1,000 lg/ml demonstrated a 76.7 ± 1.0 % or
55.9 ± 4.0 % reduction, respectively, in haemocyte
density relative to the control. This may have arisen
due to lysis of the haemocytes by the SBC3.
The humoral immune response of insects is med-
iated by a series of antimicrobial peptides and immune
related peptides (Kavanagh and Reeves 2004). The
proteomic profile of larvae that had received SBC3
was analysed in order to determine whether exposure
to the compound increased this element of the larval
immune response (Fig. 6). The results indicate that the
abundance of a number of proteins is reduced in larvae
that received SBC3 (Table 1). Proteins such as larval
Fig. 2 In vitro toxicity of SBC3 to S. aureus and C. albicans
Fig. 3 Larval survival 24 h after administration with 20 ll of
control solution (5 % DMSO) or SBC3 (10, 100, 250, 500,
1,000 lg/ml)
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haemolymph protein, 27 kDa haemolymph protein
and apolipophorin-3 were decreased in intensity. The
abundance of arylphorin was increased by 2-fold.
Discussion
Dueto themanysimilaritiesbetweenthe immunesystem
of insects and the innate immune system of mammals,
insects have become popular choices for measuring the
virulence of microbial pathogens and give results
comparable to those thatcanbeobtainedusingmammals
(Brennan et al. 2002; Jander et al. 2000). Insects have the
benefit of being inexpensive to purchase and house, and
can give results in 24–48 h. Insect can also be used to
evaluate the in vivo activity of antimicrobial drugs
(Hamamoto et al. 2004; Lionakis et al. 2005) but caution
must be exercised in their use as the introduction of
foreignmaterial into the insect haemoceol canprovoke a
non-specific immune response (Mowlds et al. 2010;
Kelly and Kavanagh 2011).
The antimicrobial activity of silver is well estab-
lished (Percival et al. 2005) and silver has been
Fig. 4 Survival of larvae infected with (a) S. aureus or (b) C. albicans following administration with SBC3 solution (20 ll of 10, 100
or 250 lg/ml) 4 h after infection
Fig. 5 Haemocyte density of larvae administered PBS, 5 %
DMSO or SBC3 (10, 100, 250, 500, 1,000 lg/ml) at 24 h
Fig. 6 2D SDS-PAGE of
separated haemolymph
proteins from G. mellonella
treated with (a) 5 % DMSO
or (b) SBC3 (100 lg/ml).
Proteins of interest (1–8)
were excised and identified
by LC/MS
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incorporated into many medical products (e.g. cathe-
ters, plasters) where it can limit the growth of bacteria
and the development of biofilms (Adams et al. 1999).
While the mode of action of silver is not fully
elucidated it has been shown to inactivate NADH and
succinate dehydrogenase and so interfere with elec-
tron transfer in respiration (Park et al. 2009). Exposure
to silver may also lead to the generation of reactive
oxygen species (ROS) which induces protein and
DNA degradation (Park et al. 2009; Atiyeh et al. 2007;
Castellano et al. 2007). Previous work demonstrated
the induction of an oxidative stress response in C.
albicans when exposed to Ag(I) ions (Rowan et al.
2010).
The experimental drug SBC3 was demonstrated to
be of low toxicity to G. mellonella larvae and the
results presented here indicated that larvae infected
with C. albicans or S. aureus and subsequently
administered SBC3 demonstrated increased survival.
SBC3 does not provoke an enhanced immune response
as indicated by the lack of an increase in the
haemocyte density and the expression of antimicrobial
and immune related peptides. A number of proteins
were shown to decrease in abundance in larvae that
received SBC3 and these included carboxylesterase
(spot 3, Table 1) which has physiological functions in
neurotransmitter degradation, hormone and phero-
mones specific metabolism, detoxification, defense
and behavior (Vogt et al. 1985; Taylor and Radic
1994), 27 kDa haemolymph protein (spot 2) which is
secreted into the haemolymph as a signal molecule
(Kelly and Kavanagh 2011) and apolipophorin-3 (spot
8) which functions in the innate immune response
(Gupta et al. 2010). Spot 6, hypothetical protein
YQE_03765 partial, was increased in abundance in
larvae that received SBC3 and functions as a death
domain protein with roles in apoptosis, immune
defense, and immune signalling (Lahm et al. 2003).
The abundance of arylphorin (spot 1), which is
involved in storage of amino acids and in aiding the
immune defence of insects (Beresford et al. 1997), was
increased in abundance by 2-fold. In contrast, admin-
istration of silver nitrate to G. mellonella larvae
stimulated the immune response by increasing the
density of circulating haemocytes (Rowan et al. 2009).
One possibility for this difference in the response ofG.
mellonella larvae to silver in silver nitrate and in
SBC3, is that silver nitrate releases ionic Ag ? and
NO3-in biological media, whereas SBC3 is covalently
bonded L-Ag-OAc (L = NHC) and no free Ag ? is
formed. The lipid nature of SBC3 may not provoke an
immune response as it may be better tolerated by the
insect’s immune system. As a consequence it can be
concluded that the increased survival of larvae that
received SBC3 is due to the anti-microbial properties
of the compound and not to a non-specific immune
response induced by the introduction of the
compound.
This is the first demonstration of the in vivo activity
of SBC3 against S. aureus and C. albicans. Future
studies will assess the mode of action of the compound
in insect larvae and mice followed by survival as well
Table 1 Identity of proteins showing alteration in abundance in larvae that received a 20 ll dose of SBC3 (100 lg/ml). (* Spectrum
Mill MS Proteomics analysis)
Spot no. Protein identity Organism Mr PI Score Sequence
coverage
(%)
Accession
no.
Relative fold change
DMSO
(Control)
100 lg
SBC3
1 Arylphorin G. mellonella 83,651 5.23 1,280 40 AAA74229 1 2.01
2 Larval hemolymph protein G. mellonella 13,783 9.08 74 10 ABG91580 1 0.80
3 Carboxylesterase G. mellonella 58,669 8.34 85 15 * 1 0.68
4 Masquerade-like serine
proteinase
P. rapae 46,063 5.54 173 7 ACZ68116 1 0.58
5 Actin-4 B. mori 42,200 5.47 560 48 AGR44814 1 0.85
6 Hypothetical protein
YQE_03765, partial
D. ponderosae 54,682 5.44 79 3 ENN79708 1 1.27
7 27 kDa hemolymph protein G. mellonella 26,387 5.17 597 57 P83632 1 0.57
8 Apolipophorin-3 G. mellonella 20,499 8.59 659 54 P80703 1 0.79
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as PK/PD studies in rodents. It is hoped that SBC3may
be developed into an intravenous antibiotic for use
against pathogenic bacteria and fungi that show
resistance to conventional antimicrobial drugs.
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